Diagnosis

  • Scientists turn human skin cells into eggs in IVF breakthrough

    Researchers have created human eggs from skin cells, in a breakthrough that could transform IVF treatment for couples who have no other options. The work remains at an early stage, but if scientists can refine the process it could allow women who are infertile due to age, illness or medical treatment to have genetically related [...]

  • Daily pill could delay menopause ‘by years,’ study finds

    Women who regularly take fish oil supplements could reduce their risk of early menopause by up to 95 per cent, new research suggests. The study, which looked at data from more than 3,500 British women, found that those who took fish oil supplements were far less likely to experience early menopause than those who did [...]

  • At-home abortions safe and effective up to 12 weeks, study finds

    At-home abortions should be permitted for up to 12 weeks across the UK, researchers say, after finding they are as safe as procedures carried out in hospital. The study reviewed outcomes of abortions between 10 and 12 weeks of pregnancy in NHS Lothian, Scotland, from 2020 to 2025. Medical abortion involves taking two drugs – [...]

  • NHS introduces new ovarian cancer screening for high-risk women

    High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with BRCA gene mutations every four months, monitoring cancer risk markers instead of requiring immediate preventive surgery. University College London Hospitals NHS Foundation Trust has begun rolling out the programme, [...]

  • HPV vaccine protects vaccinated and unvaccinated women, study finds

    A large, long-term study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine. HPV is the most common sexually transmitted infection worldwide and is the primary cause of cervical [...]

  • MS does not worsen menopause symptoms, study finds

    Menopause is not linked to increased disability accumulation in women with multiple sclerosis, according to the largest study to date. The study followed 987 Australian women with MS over 14 years, of whom 404 (40 per cent) had gone through menopause, and found no link between hormonal changes and disease progression. Led by Monash University [...]

  • Preconception BMI linked to fertility and miscarriage risks

    Preconception BMI outside the healthy range is linked to longer time to pregnancy and higher miscarriage risk, new research has revealed. The study followed 3,033 pregnancy or preconception episodes among couples in Rotterdam between August 2017 and July 2021, examining how body mass index (BMI) – weight relative to height – affects fertility. Women had [...]

  • Ovarian cancer drug to launch in UK at US price

    AbbVie said on Monday that it will launch ovarian cancer drug Elahere in the UK at the same list price as in the US. The announcement follows President Donald Trump’s push for drugmakers to align domestic prices with the lowest levels paid by comparable high-income countries under his “most-favoured-nation” policy. The US currently pays nearly [...]

  • Mothers face increased risk of depression and psychosis after childbirth – study

    Depression and psychosis are more common in women after childbirth than before, while suicide attempts fall, according to two major studies in Sweden. Researchers analysed nearly 1.8m pregnancies between 2003 and 2019 and found that mental ill health has risen over time, especially before pregnancy. During pregnancy, new diagnoses decline, but after childbirth, risks increase [...]

  • Biotech stock jumps as NHS trust rolls out ovarian cancer test

    GENinCode shares rose 6 per cent on Thursday after University College London Hospitals (UCLH) became the first NHS trust to introduce its ovarian cancer test. The AIM-listed company’s stock rose 0.25p to 4.55p after UCLH confirmed it will roll out the Risk of Ovarian Cancer Algorithm (ROCA). UCLH is offering the service through its Familial [...]